Answers are grounded in this paper and cite their sources.
Finds enhanced mucosal IgA and virologic control after intranasal vaccination, indicating a role for cell death pathways.
How tissue damage cues and regulated cell death programs instruct antigen-specific mucosal IgA after vaccination remains incompletely defined. Using a mouse model of intranasal whole-virion inactivated influenza vaccination, we identify two proximal inputs that shape antibody output and virologic control: epithelial necroptosis-associated interleukin-33 release and a macrophage death-program switch that unmasks interleukin-1α. Immunization was accompanied by lung cell death, interleukin-33 release, and the induction of antigen-specific mucosal immunoglobulin A. In alveolar macrophages, vaccine uptake required phagocytosis and was associated with lysosomal destabilization and cathepsin B activity, which were linked to interleukin-1α release under conditions that favored regulated necrotic cell death. Consistent with this, pharmacologic inhibition of caspases shifted the dominant death program in alveolar macrophages and was associated with enhanced B cell activation in the cervical lymph nodes and increased immunoglobulin A-producing cell-like populations. At the functional level, caspase inhibition augmented vaccine-elicited protection, including reduced lung viral titers and attenuated pathology after homologous challenge and improved control of a within-subtype drift influenza A virus challenge strain; these enhancements were partly dependent on interleukin-1α. Together, these data support a model in which alarmin cues and regulated cell death pathways in the lung modulate the magnitude of mucosal immunoglobulin A responses and contribute to virologic control after intranasal whole-virion inactivated influenza vaccination. Limitations include reliance on pharmacologic pathway modulation and a mouse intranasal whole-virion inactivated influenza vaccine model; thus, mechanistic generalization beyond this context should be made cautiously.
No takes yet. Share an insight, caveat, or question.
Sasaki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: